Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs151340627
rs151340627
0.010 GeneticVariation BEFREE In another family, a woman heterozygous for the W343X mutation also had nephrolithiasis. 9734595

1998

dbSNP: rs151340624
rs151340624
0.010 GeneticVariation BEFREE The R704X mutation is identical to that found in X-linked recessive nephrolithiasis, but there was no renal failure in our patient. 9893114

1999

dbSNP: rs1042636
rs1042636
0.060 GeneticVariation BEFREE In PHPT patients, only R990G polymorphism was associated with disease parameters; in comparison with R/R, R/G+G/G patients showed lower mean serum parathyroid hormone (PTH) and phosphate levels (139.9 +/- 62.2 vs 199.9 +/- 136.3 pg/ml, P < 0.05 and 0.69 +/- 0.12 vs 0.81 +/- 0.18 mmol/l, P = 0.031 respectively), higher mean 24-h urine calcium concentration and calcium excretion (9.05 +/- 2.05 vs 6.77 +/- 4.31 mmol/24 h, P = 0.012 and 67 +/- 20 vs 51 +/- 26 mumol/l GF, P = 0.039), and increased prevalence of nephrolithiasis (90.0 vs 44.2%, P = 0.007). 17062884

2006

dbSNP: rs1801726
rs1801726
0.010 GeneticVariation BEFREE We genotyped for CaSR A986S, R990G, and Q1011E polymorphisms, 119 normocalciuric and 124 hypercalciuric women with negative history of kidney stones. 17332735

2007

dbSNP: rs756322971
rs756322971
0.010 GeneticVariation BEFREE We genotyped for CaSR A986S, R990G, and Q1011E polymorphisms, 119 normocalciuric and 124 hypercalciuric women with negative history of kidney stones. 17332735

2007

dbSNP: rs1373464667
rs1373464667
0.010 GeneticVariation BEFREE The present study describes two novel compound heterozygous mutations, c.410C>T(p.T137M) (T137M) on the maternal and g.4225_50del on the paternal allele of SLC34A3, in a previously reported male with hereditary hypophosphatemic rickets with hypercalciuria (HHRH) and recurrent kidney stones (Chen C, Carpenter T, Steg N, Baron R, Anast C. Pediatrics 84: 276-280, 1989). 18480181

2008

dbSNP: rs219780
rs219780
C 0.810 GeneticVariation GWASCAT Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. 19561606

2009

dbSNP: rs219780
rs219780
C 0.810 GeneticVariation GWASDB Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. 19561606

2009

dbSNP: rs219778
rs219778
0.710 GeneticVariation GWASDB Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. 19561606

2009

dbSNP: rs219781
rs219781
0.700 GeneticVariation GWASDB Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. 19561606

2009

dbSNP: rs1014290
rs1014290
0.010 GeneticVariation BEFREE There was a weak but significant association of all 4 SNPs and nephrolithiasis (P=0.029 for rs733175; P=0.006 for rs6449213; P=0.020 for rs1014290, and P=0.011 for rs737267). 20162745

2010

dbSNP: rs6449213
rs6449213
0.010 GeneticVariation BEFREE Logistic regression in an age- and sex-adjusted model suggested that genotype C/T for rs6449213 had odds ratio for nephrolithiasis of 2.89 (95% confidence interval 1.13-7.40). 20162745

2010

dbSNP: rs733175
rs733175
0.010 GeneticVariation BEFREE There was a weak but significant association of all 4 SNPs and nephrolithiasis (P=0.029 for rs733175; P=0.006 for rs6449213; P=0.020 for rs1014290, and P=0.011 for rs737267). 20162745

2010

dbSNP: rs737267
rs737267
0.010 GeneticVariation BEFREE There was a weak but significant association of all 4 SNPs and nephrolithiasis (P=0.029 for rs733175; P=0.006 for rs6449213; P=0.020 for rs1014290, and P=0.011 for rs737267). 20162745

2010

dbSNP: rs12313273
rs12313273
0.010 GeneticVariation BEFREE On sliding window analysis the results of the 2 (rs12313273 and rs7135617) and the 3 (rs12313273, rs7135617 and rs6486795) single nucleotide polymorphism haplotypes had more significant effects on the risk of nephrolithiasis than the single nucleotide polymorphism rs12313273. 21420116

2011

dbSNP: rs6486795
rs6486795
0.010 GeneticVariation BEFREE On sliding window analysis the results of the 2 (rs12313273 and rs7135617) and the 3 (rs12313273, rs7135617 and rs6486795) single nucleotide polymorphism haplotypes had more significant effects on the risk of nephrolithiasis than the single nucleotide polymorphism rs12313273. 21420116

2011

dbSNP: rs7135617
rs7135617
0.010 GeneticVariation BEFREE On sliding window analysis the results of the 2 (rs12313273 and rs7135617) and the 3 (rs12313273, rs7135617 and rs6486795) single nucleotide polymorphism haplotypes had more significant effects on the risk of nephrolithiasis than the single nucleotide polymorphism rs12313273. 21420116

2011

dbSNP: rs13140012
rs13140012
0.010 GeneticVariation BEFREE Two SNPs in Intron 1 of MTNR1A were significantly associated with calcium nephrolithiasis: rs13140012 (P = 0.0004) and rs6553010 (P = 0.009). 21652546

2012

dbSNP: rs6553010
rs6553010
0.010 GeneticVariation BEFREE Two SNPs in Intron 1 of MTNR1A were significantly associated with calcium nephrolithiasis: rs13140012 (P = 0.0004) and rs6553010 (P = 0.009). 21652546

2012

dbSNP: rs17251221
rs17251221
0.010 GeneticVariation BEFREE Our results indicated no significant association between the CASR polymorphism (rs17251221) and the susceptibility of calcium nephrolithiasis. 21966463

2011

dbSNP: rs7652589
rs7652589
0.060 GeneticVariation BEFREE Therefore, it is a candidate gene for calcium nephrolithiasis.In a case-control study we found an association between the normocitraturic stone formers and two SNPs of CaSR, located near the promoters region (rs7652589 and rs1501899). 22107799

2011

dbSNP: rs1501899
rs1501899
0.040 GeneticVariation BEFREE Therefore, it is a candidate gene for calcium nephrolithiasis.In a case-control study we found an association between the normocitraturic stone formers and two SNPs of CaSR, located near the promoters region (rs7652589 and rs1501899). 22107799

2011

dbSNP: rs1000597
rs1000597
0.030 GeneticVariation BEFREE Here we found three novel loci for nephrolithiasis: RGS14-SLC34A1-PFN3-F12 on 5q35.3 (rs11746443; P = 8.51×10⁻¹², odds ratio (OR) = 1.19), INMT-FAM188B-AQP1 on 7p14.3 (rs1000597; P = 2.16×10⁻¹⁴, OR = 1.22), and DGKH on 13q14.1 (rs4142110; P = 4.62×10⁻⁹, OR = 1.14). 22396660

2012

dbSNP: rs11746443
rs11746443
0.030 GeneticVariation BEFREE Here we found three novel loci for nephrolithiasis: RGS14-SLC34A1-PFN3-F12 on 5q35.3 (rs11746443; P = 8.51×10⁻¹², odds ratio (OR) = 1.19), INMT-FAM188B-AQP1 on 7p14.3 (rs1000597; P = 2.16×10⁻¹⁴, OR = 1.22), and DGKH on 13q14.1 (rs4142110; P = 4.62×10⁻⁹, OR = 1.14). 22396660

2012

dbSNP: rs4142110
rs4142110
0.030 GeneticVariation BEFREE Here we found three novel loci for nephrolithiasis: RGS14-SLC34A1-PFN3-F12 on 5q35.3 (rs11746443; P = 8.51×10⁻¹², odds ratio (OR) = 1.19), INMT-FAM188B-AQP1 on 7p14.3 (rs1000597; P = 2.16×10⁻¹⁴, OR = 1.22), and DGKH on 13q14.1 (rs4142110; P = 4.62×10⁻⁹, OR = 1.14). 22396660

2012